Healthcare is one of the most promising sectors, driven by broad-based innovation with regard to therapeutical areas (eg. oncology, central nervous system, orphan diseases), medical devices or digital health. It provides ample growth opportunities while also presenting defensive characteristics.
Identifying the innovation-driven companies that best address the challenges of demography (aging population), increased prevalence of chronical illnesses or political landscape lies at the core of our approach. Drawing upon our historical roots and in view of the superior investment potential of the sector, we have specialised in Healthcare investments for more than 20 years.
In recent years Kieger has steadily expanded its expertise and product offering. We have launched two Healthcare equity funds and continue to constantly evaluate additional investment strategies in order to take full advantage of the dynamic Healthcare environment and evolving business opportunities.
We have developed a proprietary stock selection process based on in-house fundamental research and a strong collaborative approach, which allows us to take objective investment decisions in order to achieve superior investment results for our customers.